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Abstract
Shiga toxin-producing Escherichia coli (STEC) 091:H21 strain B2F1, an isolate from a patient with the hemolytic uremic syndrome
(HUS), produces elastase-activatable Shiga toxin (Stx) type 2d and adheres well to human colonic epithelial T84 cells. This adherence
phenotype occurs even though B2F1 does not contain the locus of enterocyte effacement (LEE) that encodes the primary adhesin for E. coli
O157:H7. To attempt to identify genes involved in binding of B2F1 to T84 cells a bank of mini-Tn5phoACmr transposon mutants of this
strain was generated. Several of these mutants exhibited a reduced adherence phenotype, but none of the insertions in these mutants were
within putative adhesin genes. Rather, insertional mutations within hns resulted in the loss of adherence. Moreover, the hns mutant also
displayed an increase in the production of hemolysin and alkaline phosphatase and a loss of motility with no change in Stx2d-activatable
expression levels. When B2F1 was cured of the large plasmid that encodes the hemolysin, the resulting strain adhered well to T84 cells.
However, an hns mutant of the plasmid-cured B2F1 strain exhibited a reduction in adherence to T84 cells. Taken together, these results
indicate that H-NS regulates the expression of several genes and some potential virulence factors in the intimin-negative B2F1 STEC strain
and that the large plasmid is not required for T84 cell colonization.
Published by Elsevier Science Ltd.
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1. Introduction
Strains of non-0157 STEC have been isolated from
patients with hemorrhagic colitis (HC). Some of these
isolates have been associated with the hemolytic uremic
syndrome (HUS) in infected persons [1 – 4]. Four clonallyrelated groups of STEC have been identified and are
designated EHEC 1, EHEC 2, STEC 1, and STEC 2 [5,6].
Members of EHEC groups 1 and 2 encode the locus of
enterocyte effacement (LEE) and produce intimin, an
adherence factor common to both EHEC groups [6,7]. The
O157:H7 strains that cause most of the major outbreaks of
STEC-related illness typically belong to the EHEC 1 group.
STEC 1 and 2 members typically do not encode the gene for
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intimin nor do they carry the LEE pathogenicity island [6].
Serotype 091:H21 strain B2F1 [8] lacks the LEE locus, as
determined by Southern blot with LEE-locus probes [9], and
is categorized as an STEC 1 group member. B2F1 was
originally isolated from a patient with HUS (personal
communication, Dr M. Karmali). We hypothesized that
B2F1, like other clinical isolates of intimin-negative STEC
[10 –12], has the capacity to adhere to epithelial cells by an
intimin-independent mechanism. Therefore, we attempted
to define factors important for the adherence of B2F1 to
human intestinal epithelial cells. Although an intestinal cell
adhesion for the intimin-negative 091:H21 STEC strain was
not identified, three new findings were generated from this
study. First, we found that the H-NS protein regulates, in a
positive manner, the adherence of B2F1 to T84 human
colonic epithelial cells, as well as the motility of B2F1.
Second, we demonstrated that H-NS negatively regulates
the plasmid-encoded hemolysin and chromosomally
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encoded alkaline phosphatase produced by B2F1. Third, a
plasmid-cured strain of B2F1 was used to show that the
large plasmid is not required for B2F1 to adhere to T84
cells.

2. Results and discussion
2.1. Rationale for selection of bacterial strain
and eukaryotic cells
Strain B2F1, a human 091:H21 isolate that has two
copies of the Stx2d-activatable [8,13] adhered to T84 cells
at consistently high levels (Fig. 1A). The laboratory E. coli
control strain DH5a adhered poorly to T84 cells (not
shown). T84 cells were used as the model cell line for
adherence for two reasons. First, T84 cells are not sensitive
to killing by Stx because they lack the toxin binding
receptor [14]. Second, under the appropriate in vitro
conditions the T84 human colonic adenocarcinoma cell
line grows in a polarized manner and resembles the native
intestinal colonic crypt cell from which it was derived [15].
We found that B2F1 adhered with a similar phenotype
(large irregularly shaped colonies) to both polarized and
non-polarized T84 cells (not shown). Therefore, we elected
to use non-polarized T84 cells for most of this study for ease
of maintenance and growth but confirmed all adherence
results with polarized T84 cells.
2.2. Isolation of mini-Tn5phoA Cmr adherence mutants
B2F1 was mutagenized with a mini-Tn5phoACmr
transposon to screen for mutants with insertions in potential
adhesins. The mini-Tn5phoACmr used in this study was
generated by replacing the kanamycin resistance gene in

mini-Tn5phoA [16] with a chloramphenicol resistance gene
(not shown). Chloramphenicol was used as the selective
marker in the mutagenesis rather than kanamycin because
B2F1 mutates to kanamycin resistance at a high frequency.
We isolated 22,555 chloramphenicol resistant transconjugates of B2F1. Approximately 1% of the chloramphenicol
resistant transconjugates were blue when grown on Luria –
Bertani (LB) agar with the phosphatase substrate 5-bromo4-chloro-3-indolyl phosphate (XP). The blue mutants that
contained putative active alkaline phosphatase fusions to
exported proteins were screened for the capacity to bind to
confluent T84 cells. Briefly, wild type and mutant strains
were allowed to associate with T84 cells in plastic chamber
slides for a total of 3 h at 37 8C in 5% CO2. Samples were
washed 10 times with fresh Dulbecco’s PBS supplemented
with Ca2þ/Mg2þ fixed and stained with Leukostat (modified
Wright’s stain from Fisher Scientific, New Hampshire), and
screened qualitatively by phase contrast microscopy (assay
modified from) [17,18]. Quantitative analysis was done in a
similar manner except trypsin was added to the 8-well
chamber slides after the 3 h incubation period. The
bacterial-eukaryotic cell suspension was then serially
diluted and plated on LB agar to obtain viable colony
counts. Each sample was done in triplicate. The geometric
mean adherent CFU was calculated for each strain tested. Of
the 253 mutants screened, two, 34.3 and 34.7, had a reduced
adherence phenotype (Fig. 1B shows 34.7). Quantitative
analysis of a 3 h adherence assay on polarized T84 cells
revealed that approximately 105 CFU/ml of strains 34.3 or
34.7 were recovered from each well of the chamber slide as
compared to 107 CFU/ml of wild-type B2F1.
Southern hybridization analysis of HindIII-restricted
genomic DNA from the mutants (34.7 and 34.3) with
reduced adherence showed that each mutant appeared to
contain a single insertion in an approximately 6 kb DNA
fragment (data not shown). Furthermore, double-restriction
enzyme Southern blot analysis of the two mutants revealed
that the insertion was in the same DNA fragment (data not
shown). Therefore, only 34.7 was analyzed further.
2.3. Sequence analysis of the mini-Tn5phoACmr
disrupted gene of mutant 34.7

Fig. 1. Phase contrast microscopy shows the reduced capacity of strains
with mutations in hns to adhere to T84 cells as compared to wild-type. The
parental wild-type strain B2F1 is shown in panel A and its isogenic
plasmid-cured derivative, S11, is shown in panel C; both strains exhibit a
wild-type adherence phenotype on T84 cells. In contrast, hns mutants 34.7
(panel B) and S11358.19 (panel D) are deficient in adherence. Arrows
indicate clusters of adherent bacteria.

The 6 kb HindIII DNA fragment that contained the miniTn5phoACmr from mutant 34.7 was cloned by classical
methods [19] into pBR322 and sequenced. Analysis of that
sequence revealed that the transposon had inserted near the
start of the B2F1 hns gene. However, the sequence analysis
also showed that hns and phoA were not in the same reading
frame, a finding that indicated that neither a functional HNS nor a functional alkaline phosphatase fusion protein
could be produced in 34.7. Therefore, we concluded that HNS regulates the expression of the native alkaline
phosphatase in B2F1, since 34.7 produced blue colonies
on media with XP. Other investigators have reported similar
findings when H-NS was inactivated [20].

M.E. Scott et al. / Microbial Pathogenesis 34 (2003) 155–159

2.4. Phenotypic analysis and complementation of mutant
34.7 with native H-NS
Inactivation of H-NS affects the expression of several
unlinked and unrelated genes encoded in E. coli and
Salmonella typhimurium [21,22]. Therefore, several characteristics of 34.7 that are potentially relevant to STEC
virulence were examined. Mutant 34.7 grew at rates similar
to B2F1 and expressed Stx2d-activatable at wild-type levels
(not shown), but unlike the parental B2F1 strain, mutant
34.7 was nonmotile (Table 1). However, the non-motile
phenotype of 34.7 was most likely not responsible for the
failure of 34.7 to adhere to T84 cells, since other miniTn5phoACmr non-motile mutants did adhere to T84 cells
(not shown). Strain 34.7 also produced large zones of
hemolysis on agar that contained 5% washed sheep red
blood cells (SRBCs) in contrast to the small turbid zones of
hemolysis produced by wild-type B2F1, Table 1. The
hemolysin operon is located on the large , 90 kb plasmid
carried by the vast majority of EHEC and STEC clinical
isolates [23]. However, hemolytic activity is generally not
detectable in the cell-free filtrates of wild-type STEC [23],
an observation that we confirmed with B2F1 (not shown). In
contrast, hemolytic activity was detectable in culture
supernatants of 34.7 and was quantifiable by a hemolytic
tube assay [24], Table 1. Furthermore, the amount of
hemolysin in bacterial culture supernatants and whole cell
lysates of 34.7 was greater than that produced by the parent
(Table 1), as determined by Western blot analysis with
antibody raised against a-hemolysin [24]. Thus, these
Western blot data taken together with the hemolytic
phenotype of 34.7 noted on SRBC agar and in tube assays
indicate that hemolysin production is deregulated in 34.7.
Similarly, H-NS in complex with Hha, a protein that
belongs to a relatively new family of modulators, controls
the expression of the thermoregulated a-hemolysin operon
encoded by uropathogenic Escherichia coli [25].
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The adherence capacity of mutant 34.7 was restored to
wild-type levels when hns was introduced into 34.7 on a
moderate copy number plasmid while transformation with
the vector alone failed to complement the adherence defect
of 34.7 (data not shown). This finding confirmed that the hns
mutation in 34.7 was responsible for the defect in
adherence. Similarly, the wild-type hemolytic phenotype
was restored in mutant 34.7 complemented with wild-type
hns, as demonstrated by small turbid zones of hemolysis
around the colonies on SRBC agar (not shown, see Table 1
for a summary of phenotypic data).
2.5. Construction of a hns insertion mutation in a plasmidcured derivative of B2F1 and assessment of the capacity of
that mutant to adhere to T84 cells
We next sought to separate the reduced adherence
phenotype of 34.7 from the hyper-hemolytic phenotype
exhibited in that mutant by constructing a hns mutation in a
B2F1 derivative lacking hemolysin. First, a hemolysin
negative derivative of B2F1 was generated by curing the
large plasmid from a mutant of B2F1 that carried a miniTn5phoACmr insertion on the large plasmid. The mutant
was cured by repeated passaging of the mutant in LB
containing ampicillin/cycloserine. Of 11 chloramphenicol
sensitive derivatives of the mutant, one, strain S11, was
found not to hybridize to the probe for the large plasmid [26]
and did not have a visible large plasmid present in plasmid
preparations (not shown). As expected, S11 still adhered to
T84 cells with a wild-type phenotype (Fig. 1C) and was not
hemolytic on SRBC agar (Table 1). Second, an hns mutation
was introduced into the non-hemolytic S11 by integration of
a mobilizable suicide plasmid that contained a portion of the
hns coding sequence into the wild-type hns in S11. (Note:
repeated attempts to transfer the null mutation from 34.7 to
S11 by allelic exchange or P1 transduction failed.)

Table 1
Genotypic and phenotypic characteristics of B2F1, S11 and their isogenic hns mutants
Strain

B2F1
34.7
34.7 (pHNS)
S11
S11358.19
S11358.19 (pHNS)
a

Relevant genotype

Wt
B2F1 hns < mini-Tn5phoACmr
B2F1 hns < mini-Tn5phoACmr (pHNS)
B2F1 (large plasmid cured)
S11 hns < pMS358
S11 hns < pMS358 (pHNS)

Phenotype
Alkaline phosphatasea

Adherenceb

Hemolysis (titer)c

Hemolysind

Motilitye

2/þ
þþ
2
2/þ
þ
2

þ
2
þ
þ
2
þ

2/þ(0)
þþ (8)
2/þ(ND)f
2(ND)
ND (ND)
ND (ND)

2
þ
ND
2
ND
ND

þ þþ
2
þ
þþ
þ
þ

Alkaline phosphatase was determined as blue colony color after growth on LB plates with XP.
Adherence was measured on T84 cells as described in the text.
c
Hemolysis was detected as a clearing of red blood cells around colonies grown on tryptose blood agar with 10 mM CaCl2 and 5% SRBCs. The hemolytic
titer was determined as the recipricol dilution where lysis of sheep erythrocytes was evident after 2 h at 37 8 C.
d
Hemolysin was detected by Western blot with antibody to ahemolysin [24].
e
Motility was assayed after growth in semi-solid agar plates at 30 8C overnight.
f
ND-not determined.
b
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Successful insertional inactivation of a gene by this method
has been previously reported [27].
The construction of the hns mutation in S11 is described
briefly as follows. First, a 358 bp portion of hns from S11
was amplified by the polymerase chain reaction (PCR).
Second, the truncated hns PCR product was ligated into a
temperature-sensitive suicide plasmid, pSTAMP [28], to
generate plasmid pMS358. Third, plasmid pMS358 was
electroporated into S11 and transformants that were
ampicillin resistant were recovered at 30 8C. Fourth, stable
colonies of S11 (pMS358) were incubated overnight at
44 8C on agar containing ampicillin to select for colonies
with pMS358 integrated into hns encoded on the chromosome of S11. Putative cointegrates were analyzed by PCR
and Southern blot analysis to confirm that integration of the
plasmid into hns had occurred (not shown). Insertion of the
plasmid into wild-type hns generated two incomplete copies
of hns only one of which retained an intact promoter region.
The H-NS produced from the copy of hns with an intact
promoter was predicted to lack six amino acid residues at its
carboxy-terminal end.
The in vitro growth rate of the S11 hns mutant,
S11358.19, was similar to that of wild-type S11 (not
shown). However, as predicted, S11358.19 showed reduced
adherence to T84 cells compared to S11 (Fig. 1D).
Furthermore, a quantitative adherence assay demonstrated
that 105 CFU/ml of S11358.19 were recovered as compared
to 106 CFU/ml of its parental strain S11 and B2F1. (The
reason for the lower overall adherence of the wild-type
B2F1 in this set of assays as compared to the assays
described above is unknown, however, the adherence of
B2F1 and S11 was consistently 10-fold higher than that of
the hns mutant of S11.) These results demonstrate that the
absence of H-NS function, not the presence of increased
STEC hemolysin, was responsible for the reduction in the
adherence of mutant 34.7 to T84 cells. Mutant S11358.19
was also blue on XP agar and exhibited reduced motility,
whereas the hns mutant of B2F1 was non-motile, Table 1.
This result suggested that the activity of H-NS in mutant
S11358.19 was not completely ablated. When S11358.19
was transformed with a low copy number plasmid that
encoded full-length H-NS protein, the adherence and
alkaline phosphatase phenotypes were restored to wildtype levels (not shown). However, full motility was not
restored to S11358.19 (pHNS), see Table 1. One explanation for this finding is that the truncated H-NS polypeptide produced by the mutant S11358.19 interacted with
wild-type H-NS supplied in trans, which, in turn, resulted in
a decrease in H-NS activity. Such a dominant negative
phenotype is plausible since H-NS is thought to act as an
oligomer or homodimer [22,29].
In summary, hns mutations in B2F1 or its plasmid-cured
derivative S11 reduced the capacity of those mutants to
adhere to T84 cells and resulted in a reduction in motility
and an elevation in alkaline phosphatase activity. In B2F1
the hns mutation also increased the plasmid-encoded

hemolytic activity. Regulation of STEC-hemolysin
expression in STEC or 0157:H7 has not been previously
described. Furthermore, genes encoded by the large plasmid
have not been reported to be controlled by chromosomal
gene products in STEC. In the enteropathogenic E. coli
(EPEC) regulation of attachment and effacement genes by
Ler, which is homologous to H-NS of Salmonella, has been
reported [30]. Bustamante and colleagues showed that Ler
activates transcription of LEE genes by competing for
binding with H-NS and that in the absence of Ler H-NS
represses the expression of LEE genes important in AE
lesion formation [31]. For O157:H7 EHEC strains, hns has
been suggested to be a repressor of the espA operon [32], the
products of which are involved in early steps of adherence.
Although Ler is also present in E. coli 0157:H7, intiminnegative STEC do not encode either the LEE pathogenicity
island or the Ler gene. Furthermore, our report suggests that
H-NS may play a somewhat different role in the regulation
of B2F1 adherence. The eventual identification of gene(s)
that encode STEC adhesins in LEE-negative stains will
facilitate our understanding of the mechanism by which HNS regulates adherence.
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